Overview
Complement component 3 (C3) deficiency is a rare primary immunodeficiency disorder caused by a complete or near-complete absence of complement component 3, a central protein in the complement system. C3 plays a pivotal role in all three complement activation pathways (classical, alternative, and lectin) and is essential for opsonization of pathogens, immune complex clearance, and inflammatory responses. The condition is also known as C3 deficiency or selective complement C3 deficiency. It is caused by pathogenic variants in the C3 gene located on chromosome 19p13.3. Patients with C3 deficiency typically present in early childhood with recurrent, severe bacterial infections, particularly caused by encapsulated organisms such as Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Common infections include pneumonia, meningitis, and sepsis. A significant proportion of affected individuals also develop immune complex-mediated glomerulonephritis, specifically membranoproliferative glomerulonephritis, which can progress to renal failure. This renal involvement results from impaired clearance of immune complexes due to the absence of functional C3. Some patients may also develop autoimmune manifestations, including features resembling systemic lupus erythematosus. There is no specific curative treatment for C3 deficiency. Management focuses on prompt and aggressive treatment of infections with appropriate antibiotics, prophylactic antibiotic therapy in some cases, and vaccination against encapsulated organisms, although vaccine efficacy may be reduced due to the complement deficiency. Fresh frozen plasma infusions have been used in some patients to temporarily restore C3 levels, but this approach carries risks including allergic reactions and is not a long-term solution. Renal disease is managed with standard nephrology care, and some patients may ultimately require renal transplantation. Genetic counseling is recommended for affected families.
Also known as:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Complement component 3 deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Complement component 3 deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Complement component 3 deficiency.
Community
No community posts yet. Be the first to share your experience with Complement component 3 deficiency.
Start the conversation →Latest news about Complement component 3 deficiency
1 articlesCaregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Complement component 3 deficiency
What is Complement component 3 deficiency?
Complement component 3 (C3) deficiency is a rare primary immunodeficiency disorder caused by a complete or near-complete absence of complement component 3, a central protein in the complement system. C3 plays a pivotal role in all three complement activation pathways (classical, alternative, and lectin) and is essential for opsonization of pathogens, immune complex clearance, and inflammatory responses. The condition is also known as C3 deficiency or selective complement C3 deficiency. It is caused by pathogenic variants in the C3 gene located on chromosome 19p13.3. Patients with C3 deficienc
How is Complement component 3 deficiency inherited?
Complement component 3 deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Complement component 3 deficiency typically begin?
Typical onset of Complement component 3 deficiency is childhood. Age of onset can vary across affected individuals.
Which specialists treat Complement component 3 deficiency?
17 specialists and care centers treating Complement component 3 deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.